Seoul, South Korea · Founded 2013 · Privately Held (backing)
Developer of medical aesthetic products intended to enhance skin health through polymer technology. Dexlevo is based in Seoul, South Korea and was founded in 2013. Its last reported valuation was $233 million in Nov 2021. It has raised $69.3 million.
Last reported valuation
$233.4M
Oct 2026
Priced at
—
Total raised
$69.3M
Last round
—
Cap table — not yet on record
Dexlevo's share-class structure hasn't surfaced in our sources yet. Cap tables are assembled from certificates of incorporation, round filings, and disclosures as they land.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of Dexlevo with a free account
·Watch Dexlevo: the Monday email on marks, rounds and moves
